- Published on
Toxicology – Organophosphate Poisoning
Sources
Organophosphates are found in both chemical warfare agents—such as sarin, soman, tabun, and VX—and commonly used agricultural insecticides including diazinon, dichlorvos, malathion, and parathion.
Typical Presentation
A classic case involves accidental ingestion or exposure, often in agricultural settings. Patients may present with altered mental status, pinpoint pupils (miosis), excessive secretions, slow heart rate, bronchorrhea, sweating, and respiratory distress requiring airway support.
Mechanism of Action
Organophosphates inhibit acetylcholinesterase at synapses in both the central and peripheral nervous systems, as well as in red blood cells. This leads to accumulation of acetylcholine. Over time, the enzyme undergoes “aging,” making the inhibition irreversible.
Clinical Features
Muscarinic effects are most prominent and include miosis, bradycardia, excessive salivation, sweating, bronchorrhea, bronchospasm, gastrointestinal symptoms (nausea, vomiting, diarrhea), lacrimation, and urinary incontinence. Central nervous system effects include confusion, lethargy, coma, and seizures. Nicotinic effects include muscle fasciculations and weakness. Severe toxicity may be fatal.
Management
Treatment begins with decontamination and supportive care. Atropine is administered to counteract muscarinic effects, particularly respiratory secretions, starting at 2–5 mg IV in adults (0.05 mg/kg in children) and repeated every 3–5 minutes with dose escalation until improvement is seen. Pralidoxime is used to reverse neuromuscular effects and is given intravenously over 30 minutes (1–2 g in adults, 20–50 mg/kg in children). Benzodiazepines, especially diazepam, are used for seizures, agitation, and muscle spasms. Repeated dosing or continuous infusions may be necessary. Autoinjectors containing atropine and pralidoxime are commonly used in emergency and military settings.
Sources
Organophosphates are found in both chemical warfare agents—such as sarin, soman, tabun, and VX—and commonly used agricultural insecticides including diazinon, dichlorvos, malathion, and parathion.
Typical Presentation
A classic case involves accidental ingestion or exposure, often in agricultural settings. Patients may present with altered mental status, pinpoint pupils (miosis), excessive secretions, slow heart rate, bronchorrhea, sweating, and respiratory distress requiring airway support.
Mechanism of Action
Organophosphates inhibit acetylcholinesterase at synapses in both the central and peripheral nervous systems, as well as in red blood cells. This leads to accumulation of acetylcholine. Over time, the enzyme undergoes “aging,” making the inhibition irreversible.
Clinical Features
Muscarinic effects are most prominent and include miosis, bradycardia, excessive salivation, sweating, bronchorrhea, bronchospasm, gastrointestinal symptoms (nausea, vomiting, diarrhea), lacrimation, and urinary incontinence. Central nervous system effects include confusion, lethargy, coma, and seizures. Nicotinic effects include muscle fasciculations and weakness. Severe toxicity may be fatal.
Management
Treatment begins with decontamination and supportive care. Atropine is administered to counteract muscarinic effects, particularly respiratory secretions, starting at 2–5 mg IV in adults (0.05 mg/kg in children) and repeated every 3–5 minutes with dose escalation until improvement is seen. Pralidoxime is used to reverse neuromuscular effects and is given intravenously over 30 minutes (1–2 g in adults, 20–50 mg/kg in children). Benzodiazepines, especially diazepam, are used for seizures, agitation, and muscle spasms. Repeated dosing or continuous infusions may be necessary. Autoinjectors containing atropine and pralidoxime are commonly used in emergency and military settings.
- Published on
Toxicology – Anticholinergic Toxidrome
Common Sources
Anticholinergic toxicity can arise from a wide range of medications and substances, including antihistamines, gastrointestinal and genitourinary antispasmodics, tricyclic antidepressants, antiparkinsonian drugs, skeletal muscle relaxants, antivertigo agents, antipsychotics, and plants such as Jimson weed.
Typical Presentation
A common scenario involves a teenager ingesting Jimson weed seeds for recreational purposes. Within a few hours, the individual may develop abnormal behavior, confusion, and delirium, often appearing to respond to internal stimuli. Physical findings may include dilated pupils, dry lips, rapid heart rate, and absent bowel sounds. Urinary retention is also common and may be significant.
Clinical Features
Key signs and symptoms include mydriasis, dry mucous membranes, tachycardia, hyperthermia, hypertension, decreased or absent bowel sounds, warm flushed skin, urinary retention, and altered mental status ranging from confusion to hallucinations and delirium. Severe cases may involve seizures.
Mechanism of Action
These agents block the effects of acetylcholine at muscarinic receptors within the autonomic nervous system. This affects multiple organ systems, including the brain, heart, glands, and smooth muscle of the gastrointestinal and genitourinary tracts. At higher doses, nicotinic receptor blockade may also occur. Atropine is the classic example of an anticholinergic agent.
Management
Treatment is primarily supportive. This includes intravenous fluids, bladder decompression with a Foley catheter if urinary retention is present, cooling measures for hyperthermia, and benzodiazepines for agitation or seizures. Activated charcoal may be used to reduce further absorption if appropriate. Physostigmine, a reversible acetylcholinesterase inhibitor that crosses the blood–brain barrier, may be used as an antidote in selected cases.
Key Points
Common Sources
Anticholinergic toxicity can arise from a wide range of medications and substances, including antihistamines, gastrointestinal and genitourinary antispasmodics, tricyclic antidepressants, antiparkinsonian drugs, skeletal muscle relaxants, antivertigo agents, antipsychotics, and plants such as Jimson weed.
Typical Presentation
A common scenario involves a teenager ingesting Jimson weed seeds for recreational purposes. Within a few hours, the individual may develop abnormal behavior, confusion, and delirium, often appearing to respond to internal stimuli. Physical findings may include dilated pupils, dry lips, rapid heart rate, and absent bowel sounds. Urinary retention is also common and may be significant.
Clinical Features
Key signs and symptoms include mydriasis, dry mucous membranes, tachycardia, hyperthermia, hypertension, decreased or absent bowel sounds, warm flushed skin, urinary retention, and altered mental status ranging from confusion to hallucinations and delirium. Severe cases may involve seizures.
Mechanism of Action
These agents block the effects of acetylcholine at muscarinic receptors within the autonomic nervous system. This affects multiple organ systems, including the brain, heart, glands, and smooth muscle of the gastrointestinal and genitourinary tracts. At higher doses, nicotinic receptor blockade may also occur. Atropine is the classic example of an anticholinergic agent.
Management
Treatment is primarily supportive. This includes intravenous fluids, bladder decompression with a Foley catheter if urinary retention is present, cooling measures for hyperthermia, and benzodiazepines for agitation or seizures. Activated charcoal may be used to reduce further absorption if appropriate. Physostigmine, a reversible acetylcholinesterase inhibitor that crosses the blood–brain barrier, may be used as an antidote in selected cases.
Key Points
- Activated charcoal should only be administered if bowel function is intact.
- Jimson weed and similar substances are sometimes misused recreationally, especially among adolescents.
- In elderly patients, unexplained confusion and urinary retention should raise suspicion for anticholinergic toxicity, particularly after starting new medications such as antihistamines or cold remedies.
- Anticholinergic drugs should be used cautiously in older adults due to the risk of worsening cognitive impairment.
- Classic description: “dry as a bone, red as a beet, hot as a hare, mad as a hatter, and blind as a bat.”
- Published on
Infectious disease and microbiology – Pelvic inflammatory disease
Pelvic inflammatory disease (PID) is a broad term describing infection and inflammation of the upper female genital tract, including conditions such as endometritis, salpingitis, oophoritis, tubo-ovarian abscess, and pelvic peritonitis. It typically presents with lower abdominal or pelvic pain, often accompanied by abnormal vaginal discharge, dyspareunia, dysuria, or abnormal uterine bleeding.
PID is a major public health concern, with nearly 1 million cases annually in the United States, and remains one of the most common gynecologic emergencies, especially among adolescents and young women. Risk factors include multiple sexual partners, unprotected intercourse, prior episodes of PID, and recent intrauterine device (IUD) insertion, particularly within the first few weeks. Bacterial vaginosis is frequently associated but is not a sole cause.
The condition is usually polymicrobial, with the most common causative organisms being Neisseria gonorrhoeae and Chlamydia trachomatis, often in combination with anaerobic bacteria such as Bacteroides and Peptostreptococcus. Other organisms like Gardnerella vaginalis, enteric gram-negative rods, streptococci, and Mycoplasma hominis may also be involved. In rare cases, Actinomyces (especially in IUD users) or Mycobacterium tuberculosis (in developing countries) may be responsible.
Clinically, patients often report bilateral, dull pelvic pain of subacute onset, along with abnormal vaginal discharge and menstrual irregularities. Additional symptoms may include nausea, vomiting, or even right upper quadrant pain in cases of Fitz-Hugh–Curtis syndrome (perihepatitis). On examination, cervical motion tenderness, uterine tenderness, and adnexal tenderness are key findings, often accompanied by fever and mucopurulent cervical discharge.
Diagnosis is largely clinical, supported by laboratory tests such as CBC, inflammatory markers (ESR, CRP), and nucleic acid amplification tests for gonorrhea and chlamydia. Pregnancy testing is essential to exclude ectopic pregnancy. Imaging with transvaginal ultrasound or CT/MRI may be used when the diagnosis is uncertain or complications like tubo-ovarian abscess are suspected. In difficult cases, laparoscopy can provide definitive diagnosis.
Treatment requires prompt broad-spectrum antibiotic therapy targeting likely pathogens. Outpatient regimens typically include a third-generation cephalosporin (e.g., ceftriaxone) plus doxycycline, often with metronidazole for anaerobic coverage. More severe cases require hospitalization and intravenous therapy, such as cefoxitin or cefotetan plus doxycycline, or clindamycin with gentamicin. Therapy is usually continued for 14 days, and clinical improvement is expected within 72 hours.
Surgical intervention may be necessary for large or refractory tubo-ovarian abscesses. Management also includes evaluation and treatment of sexual partners to prevent reinfection. Preventive strategies focus on safe-sex practices, condom use, limiting sexual partners, and prompt treatment of sexually transmitted infections.
The prognosis is generally good with early treatment, but delayed or inadequate therapy can lead to serious complications. These include infertility (increasing with repeated episodes), ectopic pregnancy, chronic pelvic pain, and, rarely, death due to rupture of a tubo-ovarian abscess and generalized peritonitis. Early recognition and appropriate management are therefore critical to reducing long-term morbidity.
Pelvic inflammatory disease (PID) is a broad term describing infection and inflammation of the upper female genital tract, including conditions such as endometritis, salpingitis, oophoritis, tubo-ovarian abscess, and pelvic peritonitis. It typically presents with lower abdominal or pelvic pain, often accompanied by abnormal vaginal discharge, dyspareunia, dysuria, or abnormal uterine bleeding.
PID is a major public health concern, with nearly 1 million cases annually in the United States, and remains one of the most common gynecologic emergencies, especially among adolescents and young women. Risk factors include multiple sexual partners, unprotected intercourse, prior episodes of PID, and recent intrauterine device (IUD) insertion, particularly within the first few weeks. Bacterial vaginosis is frequently associated but is not a sole cause.
The condition is usually polymicrobial, with the most common causative organisms being Neisseria gonorrhoeae and Chlamydia trachomatis, often in combination with anaerobic bacteria such as Bacteroides and Peptostreptococcus. Other organisms like Gardnerella vaginalis, enteric gram-negative rods, streptococci, and Mycoplasma hominis may also be involved. In rare cases, Actinomyces (especially in IUD users) or Mycobacterium tuberculosis (in developing countries) may be responsible.
Clinically, patients often report bilateral, dull pelvic pain of subacute onset, along with abnormal vaginal discharge and menstrual irregularities. Additional symptoms may include nausea, vomiting, or even right upper quadrant pain in cases of Fitz-Hugh–Curtis syndrome (perihepatitis). On examination, cervical motion tenderness, uterine tenderness, and adnexal tenderness are key findings, often accompanied by fever and mucopurulent cervical discharge.
Diagnosis is largely clinical, supported by laboratory tests such as CBC, inflammatory markers (ESR, CRP), and nucleic acid amplification tests for gonorrhea and chlamydia. Pregnancy testing is essential to exclude ectopic pregnancy. Imaging with transvaginal ultrasound or CT/MRI may be used when the diagnosis is uncertain or complications like tubo-ovarian abscess are suspected. In difficult cases, laparoscopy can provide definitive diagnosis.
Treatment requires prompt broad-spectrum antibiotic therapy targeting likely pathogens. Outpatient regimens typically include a third-generation cephalosporin (e.g., ceftriaxone) plus doxycycline, often with metronidazole for anaerobic coverage. More severe cases require hospitalization and intravenous therapy, such as cefoxitin or cefotetan plus doxycycline, or clindamycin with gentamicin. Therapy is usually continued for 14 days, and clinical improvement is expected within 72 hours.
Surgical intervention may be necessary for large or refractory tubo-ovarian abscesses. Management also includes evaluation and treatment of sexual partners to prevent reinfection. Preventive strategies focus on safe-sex practices, condom use, limiting sexual partners, and prompt treatment of sexually transmitted infections.
The prognosis is generally good with early treatment, but delayed or inadequate therapy can lead to serious complications. These include infertility (increasing with repeated episodes), ectopic pregnancy, chronic pelvic pain, and, rarely, death due to rupture of a tubo-ovarian abscess and generalized peritonitis. Early recognition and appropriate management are therefore critical to reducing long-term morbidity.
- Published on
Infectious disease and microbiology – Orchitis
Orchitis is an inflammatory condition of the testes, most commonly caused by infection. It often occurs alongside epididymitis (epididymo-orchitis), in which case both conditions share similar causative organisms. Unlike many other genitourinary infections, viral causes—especially mumps—play a significant role, particularly in isolated orchitis. Although relatively uncommon compared to other urinary tract infections in men, orchitis is frequently encountered in outpatient settings and is associated with epididymitis in up to 20–40% of cases.
The infection typically develops through either direct spread from the epididymis or hematogenous dissemination in primary testicular infection. Risk factors include urethral catheterization, sexually transmitted infections (STIs), and underlying epididymitis, while prevention focuses on safe sexual practices and vaccination against mumps.
The etiology varies by age and risk profile. In younger men (14–35 years), the most common bacterial causes are Neisseria gonorrhoeae and Chlamydia trachomatis, whereas in older individuals, enteric Gram-negative bacteria such as Escherichia coli, Klebsiella, and Proteus predominate. Viral orchitis is most frequently caused by mumps virus, particularly in post-pubertal males, where it occurs in 20–30% of infections. Less commonly, fungi and rare pathogens such as Brucella or Mycobacterium tuberculosis may be involved.
Clinically, patients present with testicular pain, swelling, and tenderness, often accompanied by fever, nausea, and systemic symptoms. Viral orchitis, especially mumps-related, typically has an abrupt onset, often following parotitis by several days. The condition usually resolves within 1–2 weeks, although residual tenderness may persist. On examination, testicular enlargement with a preserved cremasteric reflex is typical, helping differentiate it from testicular torsion—a critical diagnosis that must always be excluded.
Diagnosis is based on clinical findings supported by laboratory tests and imaging. Urinalysis, urine culture, and testing for STIs (including PCR for Chlamydia and Gonorrhea) are essential. In suspected viral cases, serologic testing or PCR can confirm the diagnosis. Color Doppler ultrasonography is particularly important to rule out testicular torsion, which is the most urgent differential diagnosis.
Management depends on the underlying cause. Bacterial orchitis is treated with appropriate antibiotics, often covering both gonorrhea and chlamydia empirically (e.g., ceftriaxone plus doxycycline). Enteric infections are treated with β-lactam/β-lactamase inhibitors, cephalosporins, or fluoroquinolones. In contrast, viral orchitis has no specific antiviral treatment, and management is supportive, including rest, scrotal elevation, and cold compresses. Surgical intervention may be required in cases of abscess formation or complications.
The prognosis is generally favorable, especially in viral cases like mumps orchitis, which rarely leads to infertility, although testicular atrophy and abnormalities in sperm parameters may occur. Potential complications include testicular infarction, abscess formation, pyocele, and, rarely, infertility, emphasizing the importance of timely diagnosis and appropriate management.
Orchitis is an inflammatory condition of the testes, most commonly caused by infection. It often occurs alongside epididymitis (epididymo-orchitis), in which case both conditions share similar causative organisms. Unlike many other genitourinary infections, viral causes—especially mumps—play a significant role, particularly in isolated orchitis. Although relatively uncommon compared to other urinary tract infections in men, orchitis is frequently encountered in outpatient settings and is associated with epididymitis in up to 20–40% of cases.
The infection typically develops through either direct spread from the epididymis or hematogenous dissemination in primary testicular infection. Risk factors include urethral catheterization, sexually transmitted infections (STIs), and underlying epididymitis, while prevention focuses on safe sexual practices and vaccination against mumps.
The etiology varies by age and risk profile. In younger men (14–35 years), the most common bacterial causes are Neisseria gonorrhoeae and Chlamydia trachomatis, whereas in older individuals, enteric Gram-negative bacteria such as Escherichia coli, Klebsiella, and Proteus predominate. Viral orchitis is most frequently caused by mumps virus, particularly in post-pubertal males, where it occurs in 20–30% of infections. Less commonly, fungi and rare pathogens such as Brucella or Mycobacterium tuberculosis may be involved.
Clinically, patients present with testicular pain, swelling, and tenderness, often accompanied by fever, nausea, and systemic symptoms. Viral orchitis, especially mumps-related, typically has an abrupt onset, often following parotitis by several days. The condition usually resolves within 1–2 weeks, although residual tenderness may persist. On examination, testicular enlargement with a preserved cremasteric reflex is typical, helping differentiate it from testicular torsion—a critical diagnosis that must always be excluded.
Diagnosis is based on clinical findings supported by laboratory tests and imaging. Urinalysis, urine culture, and testing for STIs (including PCR for Chlamydia and Gonorrhea) are essential. In suspected viral cases, serologic testing or PCR can confirm the diagnosis. Color Doppler ultrasonography is particularly important to rule out testicular torsion, which is the most urgent differential diagnosis.
Management depends on the underlying cause. Bacterial orchitis is treated with appropriate antibiotics, often covering both gonorrhea and chlamydia empirically (e.g., ceftriaxone plus doxycycline). Enteric infections are treated with β-lactam/β-lactamase inhibitors, cephalosporins, or fluoroquinolones. In contrast, viral orchitis has no specific antiviral treatment, and management is supportive, including rest, scrotal elevation, and cold compresses. Surgical intervention may be required in cases of abscess formation or complications.
The prognosis is generally favorable, especially in viral cases like mumps orchitis, which rarely leads to infertility, although testicular atrophy and abnormalities in sperm parameters may occur. Potential complications include testicular infarction, abscess formation, pyocele, and, rarely, infertility, emphasizing the importance of timely diagnosis and appropriate management.
- Published on
Infectious disease and microbiology – Odontogenic infections
Odontogenic infections are infections originating from the teeth or their supporting structures, ranging from minor localized lesions (e.g., dental caries, pulpitis, periapical abscess) to severe deep tissue infections that can spread into the neck and surrounding fascial spaces. These infections are among the most common reasons for dental consultations worldwide, with conditions such as periapical abscesses, periodontal abscesses, and pericoronitis being frequent emergency presentations.
They arise from disruption of the normal oral biofilm, a complex bacterial ecosystem on tooth surfaces. Poor oral hygiene or systemic conditions can alter this balance, allowing pathogenic organisms to proliferate. The infections are typically polymicrobial, involving a mix of aerobic and anaerobic bacteria, most commonly Streptococcus species, anaerobes like Fusobacterium, Peptostreptococcus, and Actinomyces, and others. As disease progresses, there is often a shift from Gram-positive organisms in early gingivitis to Gram-negative anaerobes in advanced periodontitis.
Risk factors include poor oral hygiene, diabetes, immunodeficiency, malnutrition, smoking, pregnancy, advanced age, and reduced salivation. Hospitalized patients may have increased colonization with Gram-negative organisms, increasing the risk of more severe infections. Preventive strategies focus on maintaining oral hygiene, fluoride use, plaque control (e.g., chlorhexidine), and regular dental care.
Clinically, presentation varies by the specific condition. Pulpitis and periapical abscesses typically begin with tooth sensitivity to hot or cold, progressing to persistent, throbbing pain. Gingivitis presents with inflamed, bleeding gums and halitosis, while periodontitis leads to tooth mobility, pain, and pus formation due to destruction of supporting tissues. Severe infections may extend into deep fascial spaces, causing swelling, fever, trismus, dysphagia, and systemic illness.
Diagnosis is primarily clinical, supported by dental imaging such as X-rays, which can identify bone loss, abscesses, and structural damage. Advanced imaging (CT or MRI) is used when infection spreads beyond the oral cavity. Microbiological testing may help guide therapy, although infections are usually polymicrobial.
Management aims to eliminate the source of infection and reduce bacterial load. This typically involves mechanical debridement, drainage of abscesses, and removal of the affected tooth if necessary. Antibiotics are reserved for systemic involvement or severe local spread, with common choices including penicillin, clindamycin, amoxicillin-clavulanate, or combinations such as ampicillin with metronidazole. Regular dental follow-up and periodontal care are essential to prevent recurrence.
Complications can be serious if untreated, including osteomyelitis of the jaw, necrotizing fasciitis, sinusitis, orbital infections, and intracranial spread. A particularly dangerous condition is Ludwig’s angina, a rapidly progressing bilateral infection of the floor of the mouth that can compromise the airway. Other rare but severe complications include cavernous sinus thrombosis, brain abscess, and Lemierre’s syndrome, underscoring the importance of early recognition and treatment.
Odontogenic infections are infections originating from the teeth or their supporting structures, ranging from minor localized lesions (e.g., dental caries, pulpitis, periapical abscess) to severe deep tissue infections that can spread into the neck and surrounding fascial spaces. These infections are among the most common reasons for dental consultations worldwide, with conditions such as periapical abscesses, periodontal abscesses, and pericoronitis being frequent emergency presentations.
They arise from disruption of the normal oral biofilm, a complex bacterial ecosystem on tooth surfaces. Poor oral hygiene or systemic conditions can alter this balance, allowing pathogenic organisms to proliferate. The infections are typically polymicrobial, involving a mix of aerobic and anaerobic bacteria, most commonly Streptococcus species, anaerobes like Fusobacterium, Peptostreptococcus, and Actinomyces, and others. As disease progresses, there is often a shift from Gram-positive organisms in early gingivitis to Gram-negative anaerobes in advanced periodontitis.
Risk factors include poor oral hygiene, diabetes, immunodeficiency, malnutrition, smoking, pregnancy, advanced age, and reduced salivation. Hospitalized patients may have increased colonization with Gram-negative organisms, increasing the risk of more severe infections. Preventive strategies focus on maintaining oral hygiene, fluoride use, plaque control (e.g., chlorhexidine), and regular dental care.
Clinically, presentation varies by the specific condition. Pulpitis and periapical abscesses typically begin with tooth sensitivity to hot or cold, progressing to persistent, throbbing pain. Gingivitis presents with inflamed, bleeding gums and halitosis, while periodontitis leads to tooth mobility, pain, and pus formation due to destruction of supporting tissues. Severe infections may extend into deep fascial spaces, causing swelling, fever, trismus, dysphagia, and systemic illness.
Diagnosis is primarily clinical, supported by dental imaging such as X-rays, which can identify bone loss, abscesses, and structural damage. Advanced imaging (CT or MRI) is used when infection spreads beyond the oral cavity. Microbiological testing may help guide therapy, although infections are usually polymicrobial.
Management aims to eliminate the source of infection and reduce bacterial load. This typically involves mechanical debridement, drainage of abscesses, and removal of the affected tooth if necessary. Antibiotics are reserved for systemic involvement or severe local spread, with common choices including penicillin, clindamycin, amoxicillin-clavulanate, or combinations such as ampicillin with metronidazole. Regular dental follow-up and periodontal care are essential to prevent recurrence.
Complications can be serious if untreated, including osteomyelitis of the jaw, necrotizing fasciitis, sinusitis, orbital infections, and intracranial spread. A particularly dangerous condition is Ludwig’s angina, a rapidly progressing bilateral infection of the floor of the mouth that can compromise the airway. Other rare but severe complications include cavernous sinus thrombosis, brain abscess, and Lemierre’s syndrome, underscoring the importance of early recognition and treatment.
- Published on
Toxicology – Single-Dose Lethal Toxins
Clinicians should be aware that even a single dose of certain medications can be fatal, particularly in infants and children. The following are important high-risk agents and their mechanisms:
Alpha-2 Adrenergic Agonists (e.g., Clonidine)
These centrally acting agents can lead to significant central nervous system depression, bradycardia, hypotension, and respiratory depression.
Beta-Blockers (e.g., Propranolol)
Propranolol is especially dangerous due to its lipophilic nature, allowing central nervous system penetration. Toxicity may result in hypoglycemia, altered mental status, bradycardia, hypotension, heart block, and seizures.
Calcium Channel Blockers
These drugs impair cardiac conduction and contractility, causing bradycardia, hypotension, and heart block. Hyperglycemia may also occur due to reduced insulin release.
Sulfonylureas
These oral hypoglycemic agents can cause profound and prolonged hypoglycemia, leading to altered mental status, seizures, and coma.
Opioids (Narcotics)
Opioids, including heroin and prescription medications, can cause severe respiratory depression or arrest. Ingestion of transdermal patches is a particular risk in children.
Nicotine
Nicotine toxicity can produce cholinergic symptoms such as muscle fasciculations, along with cardiovascular and neurological effects.
Tricyclic Antidepressants (TCAs)
TCAs block cardiac sodium channels, resulting in conduction delays, widened QRS complexes, and potentially fatal arrhythmias.
Salicylates
Substances such as oil of wintergreen and certain bismuth-containing compounds disrupt oxidative phosphorylation, leading to metabolic acidosis, cerebral edema, pulmonary edema, seizures, and death.
Camphor
Camphor ingestion can rapidly cause nausea, vomiting, tachycardia, central nervous system depression, and seizures, especially in children.
Colchicine and Podophyllin
These agents disrupt microtubule formation, impairing cell division. Toxicity presents with gastrointestinal symptoms and can progress to hypotension and multisystem organ failure.
Acetylcholinesterase Inhibitors (AChEIs)
Medications used for Alzheimer disease can lead to a cholinergic toxidrome in overdose, with symptoms including bradycardia, bronchorrhea, and altered mental status.
Quinine and Quinidine
These agents block sodium channels, leading to cardiac conduction abnormalities such as QRS widening, QT prolongation, and potentially life-threatening arrhythmias.
49
Clinicians should be aware that even a single dose of certain medications can be fatal, particularly in infants and children. The following are important high-risk agents and their mechanisms:
Alpha-2 Adrenergic Agonists (e.g., Clonidine)
These centrally acting agents can lead to significant central nervous system depression, bradycardia, hypotension, and respiratory depression.
Beta-Blockers (e.g., Propranolol)
Propranolol is especially dangerous due to its lipophilic nature, allowing central nervous system penetration. Toxicity may result in hypoglycemia, altered mental status, bradycardia, hypotension, heart block, and seizures.
Calcium Channel Blockers
These drugs impair cardiac conduction and contractility, causing bradycardia, hypotension, and heart block. Hyperglycemia may also occur due to reduced insulin release.
Sulfonylureas
These oral hypoglycemic agents can cause profound and prolonged hypoglycemia, leading to altered mental status, seizures, and coma.
Opioids (Narcotics)
Opioids, including heroin and prescription medications, can cause severe respiratory depression or arrest. Ingestion of transdermal patches is a particular risk in children.
Nicotine
Nicotine toxicity can produce cholinergic symptoms such as muscle fasciculations, along with cardiovascular and neurological effects.
Tricyclic Antidepressants (TCAs)
TCAs block cardiac sodium channels, resulting in conduction delays, widened QRS complexes, and potentially fatal arrhythmias.
Salicylates
Substances such as oil of wintergreen and certain bismuth-containing compounds disrupt oxidative phosphorylation, leading to metabolic acidosis, cerebral edema, pulmonary edema, seizures, and death.
Camphor
Camphor ingestion can rapidly cause nausea, vomiting, tachycardia, central nervous system depression, and seizures, especially in children.
Colchicine and Podophyllin
These agents disrupt microtubule formation, impairing cell division. Toxicity presents with gastrointestinal symptoms and can progress to hypotension and multisystem organ failure.
Acetylcholinesterase Inhibitors (AChEIs)
Medications used for Alzheimer disease can lead to a cholinergic toxidrome in overdose, with symptoms including bradycardia, bronchorrhea, and altered mental status.
Quinine and Quinidine
These agents block sodium channels, leading to cardiac conduction abnormalities such as QRS widening, QT prolongation, and potentially life-threatening arrhythmias.
49
- Published on
Toxicology – Odor-Associated Toxins
Bitter Almond Odor
This characteristic smell is classically associated with cyanide exposure, although a significant portion of the population cannot detect it due to genetic variation.
Garlic-Like Odor
Substances such as phosphorus, arsenic compounds (arsine), organophosphates, selenium, thallium, and dimethyl sulfoxide (DMSO) may produce a garlic-like smell.
Rotten Egg Odor
Hydrogen sulfide, carbon disulfide, mercaptans, disulfiram, and N-acetylcysteine are known to emit a sulfurous “rotten egg” odor.
Fruity Odor
A sweet or fruity smell may be present in exposures involving nitriles, ketoacidosis, ethanol, isopropanol, chloroform, trichloroethane, paraldehyde, chloral hydrate, methyl bromide, and certain nitrites.
Fishy or Musty Odor
Compounds such as zinc phosphide, aluminum phosphide, and nickel carbonyl may produce a fishy or musty scent.
Ammonia-Like Odor
Ammonia exposure is associated with a sharp, pungent odor that is easily recognizable.
Mothball Odor
Naphthalene, camphor, and p-dichlorobenzene commonly produce the classic mothball smell.
Minty Odor
Methylsalicylate (oil of wintergreen) and menthol can give off a distinct mint-like aroma.
Disinfectant Odor
Phenol and creosote are associated with a strong antiseptic or disinfectant-like smell.
Burnt Rope Odor
This smell may be linked to marijuana or opium exposure.
Carrot-Like Odor
Cicutoxin, found in water hemlock, can produce an odor reminiscent of carrots.
Hay-Like Odor
Phosgene exposure may be associated with a freshly cut hay smell.
Pear-Like Odor
Chloral hydrate may produce a scent resembling pears.
Pepper Odor
Exposure to riot control agents such as CS (tear gas) can result in a pepper-like smell.
Pine Odor
Pine oil is associated with a characteristic pine-like scent.
Peanut Butter Odor
Vacor, a rodenticide, has been described as having a peanut butter-like odor.
Shoe Polish Odor
Nitrobenzene exposure may produce a smell similar to shoe polish.
Tobacco Odor
Nicotine-containing substances often have a distinct tobacco-like smell.
Vinegar Odor
Acetic acid and hydrofluoric acid may emit a sharp, vinegar-like odor.
Violet Odor
Turpentine metabolites excreted in urine may produce a violet-like scent.
New Car Smell
Chemicals such as benzene, cyclohexanone, and styrene, often found in new materials, can produce this recognizable odor.
PEARLS
Bitter Almond Odor
This characteristic smell is classically associated with cyanide exposure, although a significant portion of the population cannot detect it due to genetic variation.
Garlic-Like Odor
Substances such as phosphorus, arsenic compounds (arsine), organophosphates, selenium, thallium, and dimethyl sulfoxide (DMSO) may produce a garlic-like smell.
Rotten Egg Odor
Hydrogen sulfide, carbon disulfide, mercaptans, disulfiram, and N-acetylcysteine are known to emit a sulfurous “rotten egg” odor.
Fruity Odor
A sweet or fruity smell may be present in exposures involving nitriles, ketoacidosis, ethanol, isopropanol, chloroform, trichloroethane, paraldehyde, chloral hydrate, methyl bromide, and certain nitrites.
Fishy or Musty Odor
Compounds such as zinc phosphide, aluminum phosphide, and nickel carbonyl may produce a fishy or musty scent.
Ammonia-Like Odor
Ammonia exposure is associated with a sharp, pungent odor that is easily recognizable.
Mothball Odor
Naphthalene, camphor, and p-dichlorobenzene commonly produce the classic mothball smell.
Minty Odor
Methylsalicylate (oil of wintergreen) and menthol can give off a distinct mint-like aroma.
Disinfectant Odor
Phenol and creosote are associated with a strong antiseptic or disinfectant-like smell.
Burnt Rope Odor
This smell may be linked to marijuana or opium exposure.
Carrot-Like Odor
Cicutoxin, found in water hemlock, can produce an odor reminiscent of carrots.
Hay-Like Odor
Phosgene exposure may be associated with a freshly cut hay smell.
Pear-Like Odor
Chloral hydrate may produce a scent resembling pears.
Pepper Odor
Exposure to riot control agents such as CS (tear gas) can result in a pepper-like smell.
Pine Odor
Pine oil is associated with a characteristic pine-like scent.
Peanut Butter Odor
Vacor, a rodenticide, has been described as having a peanut butter-like odor.
Shoe Polish Odor
Nitrobenzene exposure may produce a smell similar to shoe polish.
Tobacco Odor
Nicotine-containing substances often have a distinct tobacco-like smell.
Vinegar Odor
Acetic acid and hydrofluoric acid may emit a sharp, vinegar-like odor.
Violet Odor
Turpentine metabolites excreted in urine may produce a violet-like scent.
New Car Smell
Chemicals such as benzene, cyclohexanone, and styrene, often found in new materials, can produce this recognizable odor.
PEARLS
- Approximately 40% of individuals are unable to detect the bitter almond odor of cyanide.
- Hydrogen sulfide exposure can quickly lead to olfactory fatigue, reducing the ability to perceive its smell.
- Published on
Toxicology – Seizure-Inducing Toxins
Cocaine
Cocaine lowers the seizure threshold through potent stimulation of the central nervous system, similar to other sympathomimetic agents.
Isoniazid
Isoniazid toxicity can cause severe, refractory seizures that are characteristically resistant to standard therapy and require treatment with pyridoxine.
Anticholinergics
Seizures may occur as a late and severe manifestation of anticholinergic toxicity.
Amphetamines
Amphetamines increase catecholamine release and significantly lower the seizure threshold, increasing the risk of seizures.
Organophosphates
These insecticides produce a cholinergic toxidrome and can lead to seizures due to excessive acetylcholine accumulation.
Ethanol Withdrawal
Seizures may develop within 6 to 48 hours after abrupt cessation of alcohol in dependent individuals.
Tricyclic Antidepressants (TCAs)
At high doses, TCAs can induce seizures, often occurring before serious cardiac complications such as arrhythmias or arrest.
Methylanthines
Agents such as theophylline can cause seizures in overdose due to central nervous system stimulation.
Phencyclidine (PCP)
Large doses of PCP may result in severe toxicity, including seizures, hyperthermia, coma, and death.
Lidocaine
Intravenous toxicity from local anesthetics like lidocaine can initially cause seizures, followed by cardiovascular collapse.
Camphor
Camphor exposure, especially in children, can lead to seizures due to increased absorption through ingestion or skin contact.
Sympathomimetics
This class of drugs broadly lowers the seizure threshold through increased adrenergic activity.
Benzodiazepine Withdrawal
Abrupt discontinuation of benzodiazepines can lead to withdrawal symptoms, including seizures. Use of flumazenil may precipitate acute withdrawal in dependent individuals.
Lithium
Severe lithium toxicity may present with neurological complications, including seizures.
Lindane
Lindane, used topically for lice and scabies, can cause seizures when absorbed in excessive amounts, particularly in infants and children.
Lead (Severe Toxicity)
Extremely elevated lead levels can result in neurological toxicity, including seizures.
Treatment
Benzodiazepines such as diazepam or lorazepam are first-line therapy for toxin-induced seizures. If seizures persist, phenobarbital is considered second-line. In refractory cases, propofol with airway protection may be required. Phenytoin and fosphenytoin are generally not effective for toxin-induced seizures. Pyridoxine should be administered when isoniazid or certain mushroom toxicities are suspected.
Cocaine
Cocaine lowers the seizure threshold through potent stimulation of the central nervous system, similar to other sympathomimetic agents.
Isoniazid
Isoniazid toxicity can cause severe, refractory seizures that are characteristically resistant to standard therapy and require treatment with pyridoxine.
Anticholinergics
Seizures may occur as a late and severe manifestation of anticholinergic toxicity.
Amphetamines
Amphetamines increase catecholamine release and significantly lower the seizure threshold, increasing the risk of seizures.
Organophosphates
These insecticides produce a cholinergic toxidrome and can lead to seizures due to excessive acetylcholine accumulation.
Ethanol Withdrawal
Seizures may develop within 6 to 48 hours after abrupt cessation of alcohol in dependent individuals.
Tricyclic Antidepressants (TCAs)
At high doses, TCAs can induce seizures, often occurring before serious cardiac complications such as arrhythmias or arrest.
Methylanthines
Agents such as theophylline can cause seizures in overdose due to central nervous system stimulation.
Phencyclidine (PCP)
Large doses of PCP may result in severe toxicity, including seizures, hyperthermia, coma, and death.
Lidocaine
Intravenous toxicity from local anesthetics like lidocaine can initially cause seizures, followed by cardiovascular collapse.
Camphor
Camphor exposure, especially in children, can lead to seizures due to increased absorption through ingestion or skin contact.
Sympathomimetics
This class of drugs broadly lowers the seizure threshold through increased adrenergic activity.
Benzodiazepine Withdrawal
Abrupt discontinuation of benzodiazepines can lead to withdrawal symptoms, including seizures. Use of flumazenil may precipitate acute withdrawal in dependent individuals.
Lithium
Severe lithium toxicity may present with neurological complications, including seizures.
Lindane
Lindane, used topically for lice and scabies, can cause seizures when absorbed in excessive amounts, particularly in infants and children.
Lead (Severe Toxicity)
Extremely elevated lead levels can result in neurological toxicity, including seizures.
Treatment
Benzodiazepines such as diazepam or lorazepam are first-line therapy for toxin-induced seizures. If seizures persist, phenobarbital is considered second-line. In refractory cases, propofol with airway protection may be required. Phenytoin and fosphenytoin are generally not effective for toxin-induced seizures. Pyridoxine should be administered when isoniazid or certain mushroom toxicities are suspected.
- Published on
Toxicology – Radiopaque Toxins
Iron
Iron preparations, particularly ferrous sulfate tablets, are clearly visible on radiographs. In large ingestions, they may accumulate and form a radiopaque pharmacobezoar.
Lead (Pb)
Lead-containing objects such as paint chips, bullets, toys, and figurines are highly radiopaque and easily identified on imaging.
Calcium
Calcium-containing substances are radiopaque, and significant ingestion can result in formation of a visible mass within the gastrointestinal tract.
Barium
Barium is inherently radiopaque and readily detectable on imaging studies.
Potassium
Potassium tablets may be visualized on radiographs, especially when ingested in large amounts, sometimes forming a pharmacobezoar.
Heavy Metals
Various heavy metals are radiopaque and can be identified on plain radiographs.
Enteric-Coated or Sustained-Release Tablets
Large ingestions of these formulations can lead to the formation of a radiopaque pharmacobezoar visible on imaging.
Arsenic
As a metallic element, arsenic is radiopaque and may be seen on radiographic studies.
Iodine
Iodine-containing compounds are radiopaque and can appear on imaging.
Chloral Hydrate and Halogenated Compounds
Certain halogenated substances, such as chloral hydrate and chloroform, may be detectable on x-ray due to their radiopaque properties.
Condom Packets (Body Packers)
Individuals who ingest drug-filled packets may show multiple uniform radiopaque densities on abdominal imaging.
Tricyclic Antidepressants (TCAs)
These medications may demonstrate variable radiopacity depending on dose and preparation.
Phosphorus
Phosphorus can be visualized on radiographs due to its radiopaque nature.
Iron
Iron preparations, particularly ferrous sulfate tablets, are clearly visible on radiographs. In large ingestions, they may accumulate and form a radiopaque pharmacobezoar.
Lead (Pb)
Lead-containing objects such as paint chips, bullets, toys, and figurines are highly radiopaque and easily identified on imaging.
Calcium
Calcium-containing substances are radiopaque, and significant ingestion can result in formation of a visible mass within the gastrointestinal tract.
Barium
Barium is inherently radiopaque and readily detectable on imaging studies.
Potassium
Potassium tablets may be visualized on radiographs, especially when ingested in large amounts, sometimes forming a pharmacobezoar.
Heavy Metals
Various heavy metals are radiopaque and can be identified on plain radiographs.
Enteric-Coated or Sustained-Release Tablets
Large ingestions of these formulations can lead to the formation of a radiopaque pharmacobezoar visible on imaging.
Arsenic
As a metallic element, arsenic is radiopaque and may be seen on radiographic studies.
Iodine
Iodine-containing compounds are radiopaque and can appear on imaging.
Chloral Hydrate and Halogenated Compounds
Certain halogenated substances, such as chloral hydrate and chloroform, may be detectable on x-ray due to their radiopaque properties.
Condom Packets (Body Packers)
Individuals who ingest drug-filled packets may show multiple uniform radiopaque densities on abdominal imaging.
Tricyclic Antidepressants (TCAs)
These medications may demonstrate variable radiopacity depending on dose and preparation.
Phosphorus
Phosphorus can be visualized on radiographs due to its radiopaque nature.
- Published on
Toxicology – Non-Anion Gap Metabolic Acidosis (HARD UP)
Hyperalimentation (TPN)
Total parenteral nutrition with excessive chloride content can result in hyperchloremic metabolic acidosis. Management involves reducing chloride and increasing acetate in the formulation. Regular monitoring with daily basic metabolic panels is important in these patients.
Acetazolamide
Acetazolamide inhibits carbonic anhydrase in the proximal tubule, leading to increased urinary bicarbonate loss and a non-anion gap metabolic acidosis. Patients may experience paresthesias in the extremities and a metallic taste.
Renal Tubular Acidosis (RTA)
Renal tubular dysfunction impairs acid and ammonia excretion, resulting in hyperchloremic metabolic acidosis. It is classified into Type I (distal, hypokalemic), Type II (proximal, hypokalemic), and Type IV (hyperkalemic). Type III is no longer recognized as a separate entity.
Diarrhea
Loss of bicarbonate through the gastrointestinal tract leads to non-anion gap metabolic acidosis. Treatment includes intravenous fluids and bicarbonate replacement.
Ureteroenteric Fistula
This condition can cause metabolic acidosis through several mechanisms: reabsorption of ammonium chloride from urine, exchange of chloride for bicarbonate in the bowel, and renal tubular impairment. Risk increases with prolonged urine exposure to bowel mucosa and greater surface area involvement.
Pancreaticoduodenal Fistula
Similar to diarrhea, this condition leads to bicarbonate loss and subsequent non-anion gap metabolic acidosis. Management focuses on fluid resuscitation and correction of electrolyte imbalances.
Hyperalimentation (TPN)
Total parenteral nutrition with excessive chloride content can result in hyperchloremic metabolic acidosis. Management involves reducing chloride and increasing acetate in the formulation. Regular monitoring with daily basic metabolic panels is important in these patients.
Acetazolamide
Acetazolamide inhibits carbonic anhydrase in the proximal tubule, leading to increased urinary bicarbonate loss and a non-anion gap metabolic acidosis. Patients may experience paresthesias in the extremities and a metallic taste.
Renal Tubular Acidosis (RTA)
Renal tubular dysfunction impairs acid and ammonia excretion, resulting in hyperchloremic metabolic acidosis. It is classified into Type I (distal, hypokalemic), Type II (proximal, hypokalemic), and Type IV (hyperkalemic). Type III is no longer recognized as a separate entity.
Diarrhea
Loss of bicarbonate through the gastrointestinal tract leads to non-anion gap metabolic acidosis. Treatment includes intravenous fluids and bicarbonate replacement.
Ureteroenteric Fistula
This condition can cause metabolic acidosis through several mechanisms: reabsorption of ammonium chloride from urine, exchange of chloride for bicarbonate in the bowel, and renal tubular impairment. Risk increases with prolonged urine exposure to bowel mucosa and greater surface area involvement.
Pancreaticoduodenal Fistula
Similar to diarrhea, this condition leads to bicarbonate loss and subsequent non-anion gap metabolic acidosis. Management focuses on fluid resuscitation and correction of electrolyte imbalances.
